Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRUSTS: Trabectedin vs Doxorubicin in Soft Tissue Sarcoma
NCT01189253Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- May 2011
- Primary completion
- Jun 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of trabectedin in soft tissue sarcoma (STS), sponsored by European Organisation for Research and Treatment of Cancer. Started May 2011; status: terminated.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01189253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189253.